StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie stock-Based Compensation Tax Benefit ($M) ($M)

Form 10-Q / 10-K Stock-Based Compensation Note

QuarterlyAnnual
Latest, Q2 2026
29
Period ended Jun 30, 2026
Change on a year earlier
-14.7%
34 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
35
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStock-Based Compensation Tax Benefit ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202629-14.7%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 202675+7.1%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 202531-3.1%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 202535+6.1%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 2025340.0%Form 10-Q (filed 2026-08-03) ↗
Q1 2025Mar 31, 202570+16.7%Form 10-Q (filed 2026-05-08) ↗
Q4 2024Dec 31, 202432+28.0%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 202433+26.9%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 202434+13.3%Form 10-Q (filed 2025-08-04) ↗
Q1 2024Mar 31, 202460+9.1%Form 10-Q (filed 2025-05-09) ↗
Q4 2023Dec 31, 202325+25.0%Form 10-K (filed 2026-02-20) ↗
Q3 2023Sep 30, 202326+4.0%Form 10-Q (filed 2024-11-04) ↗
Q2 2023Jun 30, 202330+42.9%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 202355-1.8%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 202220-20.0%Form 10-K (filed 2025-02-14) ↗
Q3 2022Sep 30, 202225-7.4%Form 10-Q (filed 2023-11-06) ↗

Cite this data

StockData. (2026). AbbVie Stock-Based Compensation Tax Benefit ($M) ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/cap_sbc_tax

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.